SVRA: Savara Inc.
Performance
SVRA +27.85%
Watchlist
Select an item
Summary
SVRA at a glance
SVRA returned +27.85% over the past year and +33.19% a year over five years. Its worst drop in that year was -39.19%, smaller than 38% of stocks on Redstone, and its Sharpe ratio of 0.65 beats 58% of stocks on Redstone. It pays no dividends.
Current Drawdown
-27.23%
Rolling Volatility
71.21%
Actions
Metrics
Risk Indicators
Alpha22.77%
Beta1.35x
Sharpe0.65
Sortino1.04
Omega1.11
Calmar0.71
Martin1.68
Profile
About SVRA
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.0B
- Listed
- Nov 1996
- Employees
- 70
- Headquarters
- Austin, TX
- Website
- savarapharma.com
Comparisons